about
Human Cytochrome P450 2W1 Is Not Expressed in Adrenal Cortex and Is Only Rarely Expressed in Adrenocortical CarcinomasRare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma.Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated geneCharacterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis.HRAS mutation prevalence and associated expression patterns in pheochromocytoma.Suppression of Forkhead Box Protein O1 (FOXO1) Transcription Factor May Promote Adrenocortical Tumorigenesis.Immunohistochemical NF1 analysis does not predict NF1 gene mutation status in pheochromocytoma.TERT promoter mutations are rare in parathyroid tumors.Sex and maturity status affected the validity of a submaximal cycle test in adolescents.Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention.Telomerase reverse transcriptase promoter hypermethylation is associated with metastatic disease in abdominal paraganglioma.Absence of KMT2D/MLL2 mutations in abdominal paraganglioma.Chromosome 19 amplification correlates with advanced disease in adrenocortical carcinoma.Absence of the BRAF V600E mutation in pheochromocytoma.Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithmsThe Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas-A Meta-Analysis and Systematic Review of the LiteratureDNA copy amplification and overexpression of SLC12A7 in adrenocortical carcinomaWhole-genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation
P50
Q28553895-103E4F31-592E-44FE-B381-09EA4456AD64Q33570108-432F0626-1E76-4B87-B663-E9D40EF5D195Q33570215-DFE16232-C370-44CE-A51D-A1FA5AEE66C1Q34478820-89E6FF7F-13E1-4E2D-A1CB-19C59AF9BF27Q35234108-F93F24FE-F5ED-44C0-BCF2-45E6E4281A68Q36294469-8B3CD13C-F76D-4E6B-973B-F0451FB1629DQ36694372-EE824C32-F465-4D79-AF50-F7EF0EFBF615Q38699325-49CD9B34-6604-4529-B12B-94A75C0BA39EQ43481604-D5E4B16E-3DAE-419C-A2FD-5D5FFE79C6D6Q45237414-1C32FFB8-E7CB-4D43-9CF2-26F0AB4F036EQ47681988-FF766311-122E-49A4-AD06-110BFDBAA89EQ47801615-63C15597-A3A7-4C2E-B157-0584B5460BBFQ48318640-A96D302C-13BE-4C26-B6A3-6B868990673FQ52150621-8D0D4E04-E3B9-4051-BD4E-79C4BF8A9D19Q53316851-9E540AF4-3E48-4BA5-BBA7-D71800ED733FQ54225773-770BC53E-45B5-456A-8DAF-481D2EE96325Q57165237-CD8221BA-7FEC-47F9-8D5D-6F4BAC7ED32BQ64245118-4FAAD6C7-DCB7-4764-9A94-1DB1D10CEBCAQ86438010-858AEBC2-4BA7-4D13-9031-63E7F3A53760Q90767863-BA84B225-58F0-4212-B2EB-6947A197968A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Adam Stenman
@ast
Adam Stenman
@en
Adam Stenman
@es
Adam Stenman
@nl
Adam Stenman
@sl
type
label
Adam Stenman
@ast
Adam Stenman
@en
Adam Stenman
@es
Adam Stenman
@nl
Adam Stenman
@sl
altLabel
Adam Andreasson
@en
prefLabel
Adam Stenman
@ast
Adam Stenman
@en
Adam Stenman
@es
Adam Stenman
@nl
Adam Stenman
@sl
P106
P21
P31
P496
0000-0003-3248-7629